Correction to “Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility”
Antonio Romero, Luke Ashcraft, Aroop Chandra, Vincent DiMassa, Peadar Cremin, Scott E. Collibee, Chihyuan Chuang, James Hartman, Darren T. Hwee, David St. Jean, Justin Malinowski, Mikkel DeBenedetto, David C. Moebius, Joshua Payette, Richard Vargas, John Yeoman, Alykhan Motani, Jeffrey Reagan, Fady I. Malik, Bradley P. Morgan
{"title":"Correction to “Discovery of Nelutroctiv (CK-136), a Selective Cardiac Troponin Activator for the Treatment of Cardiovascular Diseases Associated with Reduced Cardiac Contractility”","authors":"Antonio Romero, Luke Ashcraft, Aroop Chandra, Vincent DiMassa, Peadar Cremin, Scott E. Collibee, Chihyuan Chuang, James Hartman, Darren T. Hwee, David St. Jean, Justin Malinowski, Mikkel DeBenedetto, David C. Moebius, Joshua Payette, Richard Vargas, John Yeoman, Alykhan Motani, Jeffrey Reagan, Fady I. Malik, Bradley P. Morgan","doi":"10.1021/acs.jmedchem.4c02850","DOIUrl":null,"url":null,"abstract":"Pages 7825 and 7834. The middle initial of author David C. Moebius was omitted in the original publication and has been added in the list of authors here. Additionally, nine authors were incorrectly listed as affiliated with Cytokinetics, Inc., who are actually affiliated with Amgen, Inc., and present addresses were omitted for seven authors. The Author Information on page 7834 should be updated as shown below for the following authors: <b>Aroop Chandra</b> – <i>Cytokinetics, Inc., South San Francisco, California 94080, United States</i>; Present Address: Cortiva Agriscience, Indianapolis, Indiana, United States <b>Vincent DiMassa</b> – <i>Cytokinetics, Inc., South San Francisco, California 94080, United States</i>; Present Address: University of Nevada, Reno, Nevada, United States <b>Peadar Cremin</b> – <i>Cytokinetics, Inc., South San Francisco, California 94080, United States</i>; Present Address: Circle Pharma, South San Francisco, California, United States <b>David St. Jean</b> – <i>Amgen, Inc., Cambridge, Massachusetts 02141, United States</i>; Present Address: Scorpion Therapeutics, South San Francisco, California, United States <b>Justin Malinowski</b> – <i>Amgen, Inc., Cambridge, Massachusetts 02141, United States</i>; Present Address: Regeneron Pharmaceuticals, Tarrytown, New York, United States <b>Mikkel DeBenedetto</b> – <i>Amgen, Inc., Cambridge, Massachusetts 02141, United States</i>; Present Address: Sanofi, Cambridge, Massachusetts, United States <b>David C. Moebius</b> – <i>Amgen, Inc., Cambridge, Massachusetts 02141, United States</i>; Present Address: Moderna Therapeutics, Cambridge, Massachusetts, United States <b>Joshua Payette</b> – <i>Amgen, Inc., Cambridge, Massachusetts 02141, United States</i> <b>Richard Vargas</b> – <i>Amgen, Inc., Cambridge, Massachusetts 02141, United States</i> <b>John Yeoman</b> – <i>Amgen, Inc., Cambridge, Massachusetts 02141, United States</i> <b>Alykhan Motani</b> – <i>Amgen, Inc., South San Francisco, California 94080, United States</i> <b>Jeffrey Reagan</b> – <i>Amgen, Inc., South San Francisco, California 94080, United States</i> This article has not yet been cited by other publications.","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"97 1","pages":""},"PeriodicalIF":6.8000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02850","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Pages 7825 and 7834. The middle initial of author David C. Moebius was omitted in the original publication and has been added in the list of authors here. Additionally, nine authors were incorrectly listed as affiliated with Cytokinetics, Inc., who are actually affiliated with Amgen, Inc., and present addresses were omitted for seven authors. The Author Information on page 7834 should be updated as shown below for the following authors: Aroop Chandra – Cytokinetics, Inc., South San Francisco, California 94080, United States; Present Address: Cortiva Agriscience, Indianapolis, Indiana, United States Vincent DiMassa – Cytokinetics, Inc., South San Francisco, California 94080, United States; Present Address: University of Nevada, Reno, Nevada, United States Peadar Cremin – Cytokinetics, Inc., South San Francisco, California 94080, United States; Present Address: Circle Pharma, South San Francisco, California, United States David St. Jean – Amgen, Inc., Cambridge, Massachusetts 02141, United States; Present Address: Scorpion Therapeutics, South San Francisco, California, United States Justin Malinowski – Amgen, Inc., Cambridge, Massachusetts 02141, United States; Present Address: Regeneron Pharmaceuticals, Tarrytown, New York, United States Mikkel DeBenedetto – Amgen, Inc., Cambridge, Massachusetts 02141, United States; Present Address: Sanofi, Cambridge, Massachusetts, United States David C. Moebius – Amgen, Inc., Cambridge, Massachusetts 02141, United States; Present Address: Moderna Therapeutics, Cambridge, Massachusetts, United States Joshua Payette – Amgen, Inc., Cambridge, Massachusetts 02141, United StatesRichard Vargas – Amgen, Inc., Cambridge, Massachusetts 02141, United StatesJohn Yeoman – Amgen, Inc., Cambridge, Massachusetts 02141, United StatesAlykhan Motani – Amgen, Inc., South San Francisco, California 94080, United StatesJeffrey Reagan – Amgen, Inc., South San Francisco, California 94080, United States This article has not yet been cited by other publications.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.